# AI医疗影像诊断获FDA批准\n\n某AI医疗公司开发的影像诊断系统获得FDA批准，在肺癌早期筛查中准确率达到98%，超越人类医生水平。
affect judgment
This event will impact the AI value chain, flowing from upstream computing infrastructure to downstream application scenarios. In the short term, leading companies in relevant technology routes will benefit first. In the medium term, industry adoption will accelerate; we recommend focusing on vertical players with strong data moats and deep scenario expertise.
Correct Information
If you find any factual errors, data discrepancies, or copyright issues in this article, please contact us viaContact UsFeedback. We will verify and correct it promptly.
Reviews (0)
Please log in to comment.
Go to Login